Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr 1;69(1):1-2.
doi: 10.2344/anpr-69-01-07.

Remimazolam: The Next Evolutionary Step for Sedative-Hypnotics

Kyle J Kramer  1
Affiliations
Editorial

Remimazolam: The Next Evolutionary Step for Sedative-Hypnotics

Kyle J Kramer. Anesth Prog. .
No abstract available

PubMed Disclaimer

References

    1. Kilpatrick GJ. Remimazolam: non-clinical and clinical profile of a new sedative/anesthetic agent. Front Pharmacol . 2021;12:690875. doi: 10.3389/fphar. - DOI - PMC - PubMed
    1. Sneyd JR, Rigby-Jones AE. Remimazolam for anaesthesia or sedation. Curr Opin Anaesthesiol . 2020;33(4):506–511. doi: 10.1097/ACO.0000000000000877. - DOI - PubMed
    1. Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056), part I: safety, efficacy, and basic pharmacokinetics. Anesth Analg . 2012;115(2):274–283. doi: 10.1213/ANE.0b013e31823f0c28. - DOI - PubMed
    1. Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc . 2018;88(3):427–437.e6. doi: 10.1016/j.gie.2018.04.2351. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources